Idéal Investisseur Galteron Galteron
Français English
CAC 40 : Market open
8 283,24 pts
-0.82%


Last updated : 17/11/2026 - 11h54
🏠 Home   ➤    Stock news

Inventiva shares fall 7.5% over the week and slip back below their 20-day moving average (MM20)

The Burgundy-based biotech specializing in fibrotic and metabolic diseases eases off in mid-morning trading, in a Paris market that is declining alongside Wall Street and Asia. The stock interrupts the rebound under way since late October.


Inventiva shares fall 7.5% over the week and slip back below their 20-day moving average (MM20)

A pullback that brings the stock back below its short-term averages

Inventiva shares fell 2.38% to €3.08, while the SBF 120 lost 0.99% following a lower close on Wall Street. The stock is now below its 20-day moving average (MM20: €3.31, a gap of 7.10%) and its 50-day moving average (MM50: €3.16), while the RSI at 44 remains neutral.

After gaining more than 20% over one month, the stock has lost 7.66% over seven days and ranks among the lowest performers in the index.

The support at €2.65 is 14% below the current price, and the resistance at €3.59 is 17% above. The MACD, at 0.0407 versus 0.0622 for its signal line, remains below the latter, consistent with the slowdown of the rebound.

Cash consolidated in spring, no revenue in the first half

When the H1 2026 results were published (on 29 July 2026), Inventiva had recorded no revenue, compared with €4.5 million a year earlier.

The group also stated that its cash position did not cover operating requirements for the next twelve months without additional financing, with visibility limited to the end of the second quarter of 2027. On 2 June 2026, it had announced a €103 million capital increase and a €75 million financing transaction, of which tranche C may bring in up to €20 million. The next scheduled event is the publication of third-quarter revenue, expected on 23 November.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 0 millions d'euros
  • Quarterly revenue: 0 millions d'euros
  • Revenue growth: -100 %
  • Net income: -69,5 millions d'euros
  • Free cash flow: -48,7 millions d'euros
Risks mentioned
  • La trésorerie actuelle ne couvre pas les besoins opérationnels des 12 prochains mois.
  • Horizon de trésorerie limité à la fin du deuxième trimestre 2027 sans financements additionnels.
  • Aucun chiffre d'affaires enregistré au premier semestre 2026, contre 4,5 M€ un an plus tôt.
Opportunities identified
  • Offre Equity de 103 M€ et Opération de Financement de 75 M€ annoncées le 2 juin 2026.
  • Tranche C de l'Opération de Financement pouvant apporter jusqu'à 20,0 M€.
  • Exercice des warrants Tranche 3 pouvant générer jusqu'à 116,0 M€.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours